Tempus, a company focused on personalized oncology care, collects and analyzes large-scale databases of molecular and clinical information to support physicians treating cancer patients.
Under the agreement, Tempus will use its Tempus O platform to structure patient data from Vanderbilt-Ingram Cancer Center’s EHR. The company will also provide the cancer center with next generation sequencing and analysis services to identify actionable gene alterations.
“Collaborating with Tempus will allow the Vanderbilt-Ingram team to gain a deeper understanding of a patient’s cancer and its genetic and molecular drivers, with a goal of improving patient outcomes,” said Jennifer Pietenpol, PhD, director of the Vanderbilt-Ingram Cancer Center.
More articles on data analytics & precision medicine:
Microsoft, Google venture arms invest in genomic information startup DNAnexus
Baptist Health South Florida taps health tech startup for precision cancer care
4 questions with PotentiaMetrics CEO Robert Palmer on personalized healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
